| For: | Chaemsupaphan T, Pudipeddi A, Lin HY, Paramsothy S, Kariyawasam VC, Kermeen M, Leong RW. Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics study. World J Gastroenterol 2025; 31(2): 101292 [PMID: 39811508 DOI: 10.3748/wjg.v31.i2.101292] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i2/101292.htm |
| Number | Citing Articles |
| 1 |
Aviv Pudipeddi, Thanaboon Chaemsupaphan, Arteen Arzivian, Yong-Sul Kim, Sudarshan Paramsothy, Viraj Kariyawasam, Rupert W. Leong. Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapy. Therapeutic Advances in Gastroenterology 2026; 19 doi: 10.1177/17562848251414825
|
| 2 |
Jeffery M. Venner, Dermot P.B. McGovern, Maria T. Abreu. Current and Future Role of Precision Medicine in the Management of IBD. Current Treatment Options in Gastroenterology 2025; 23(1) doi: 10.1007/s11938-025-00483-7
|
| 3 |
Aviv Pudipeddi, Nico Pajes, Sudarshan Paramsothy, Viraj Kariyawasam, Ramesh Paramsothy, Simon Ghaly, Craig Haifer, Yoon‐Kyo An, Jakob Begun, Susan J. Connor, Crispin Corte, Mark G. Ward, Peter De Cruz, Caroline Lan‐San Fung, Diane Redmond, Webber Chan, Fadi H. Mourad, Melissa Kermeen, Rupert W. Leong. Never‐Smoking Is Associated With Histologic Remission in Ulcerative Colitis: A Post‐Hoc Analysis of the VIEWS Randomised Controlled Trial. JCC Plus 2026; 1(4) doi: 10.1002/jcc5.70051
|